Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a corticosteroid hormone stimulus. A corticosteroid is a steroid hormone that is produced in the adrenal cortex. Corticosteroids are involved in a wide range of physiologic systems such as stress response, immune response and regulation of inflammation, carbohydrate metabolism, protein catabolism, blood electrolyte levels, and behavior. They include glucocorticoids and mineralocorticoids.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to corticosteroid"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.622 | Rat | |
| IL8 | interleukin 8 | 0.605 | ||
| ANXA1 | annexin A1 | 0.479 | ||
| ESR1 | estrogen receptor 1 | 0.475 | ||
| SULT1A1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 | 0.471 | Rat | |
| SULT1A2 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | 0.385 | Rat | |
| NRP1 | neuropilin 1 | 0.382 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.345 | Human | |
| JUN | jun proto-oncogene | 0.342 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.338 | Human | |
| RNF144B | ring finger protein 144B | 0.333 | ||
| EGFR | epidermal growth factor receptor | 0.330 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.277 | Rat | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.276 | ||
| THBS1 | thrombospondin 1 | 0.257 | ||
| SULT1A4 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4 | 0.236 | Rat | |
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.231 | Rat | |
| NOSTRIN | nitric oxide synthase trafficker | 0.208 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.197 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.192 | Rat | |
| NCOA1 | nuclear receptor coactivator 1 | 0.183 | ||
| JAK2 | Janus kinase 2 | 0.175 | Mouse | |
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.160 | Rat | |
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.157 | Rat | |
| APAF1 | apoptotic peptidase activating factor 1 | 0.144 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.142 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.134 | ||
| SCP2 | sterol carrier protein 2 | 0.121 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.116 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.114 | Rat | |
| HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.104 | ||
| PLAU | plasminogen activator, urokinase | 0.099 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.098 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.092 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.089 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.080 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.080 | ||
| JUNB | jun B proto-oncogene | 0.079 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.078 | ||
| C1QA | complement component 1, q subcomponent, A chain | 0.075 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.074 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.062 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.062 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.060 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.060 | ||
| IER3 | immediate early response 3 | 0.059 | ||
| ENG | endoglin | 0.059 | ||
| S100A10 | S100 calcium binding protein A10 | 0.057 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.055 | ||
| KLHL24 | kelch-like 24 (Drosophila) | 0.052 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.051 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.051 | ||
| BCL2L1 | BCL2-like 1 | 0.050 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.049 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.049 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.048 | Mouse Rat | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.046 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.046 | ||
| PDCD6 | programmed cell death 6 | 0.046 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.045 | ||
| CCND3 | cyclin D3 | 0.044 | ||
| EP300 | E1A binding protein p300 | 0.043 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.042 | ||
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.041 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.041 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.041 | ||
| IL10RA | interleukin 10 receptor, alpha | 0.040 | ||
| CRH | corticotropin releasing hormone | 0.040 | Rat | |
| BBS1 | Bardet-Biedl syndrome 1 | 0.039 | ||
| APOA1 | apolipoprotein A-I | 0.037 | ||
| RB1 | retinoblastoma 1 | 0.036 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.036 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.036 | Human | |
| PLAUR | plasminogen activator, urokinase receptor | 0.036 | ||
| ATF3 | activating transcription factor 3 | 0.036 | ||
| SMAD3 | SMAD family member 3 | 0.035 | ||
| EMP1 | epithelial membrane protein 1 | 0.034 | ||
| RARA | retinoic acid receptor, alpha | 0.032 | ||
| HLA-DRB1 | major histocompatibility complex, class II, DR beta 1 and major histocompatibility complex, class II, DR beta 1 | 0.032 | ||
| PLAT | plasminogen activator, tissue | 0.031 | Rat | |
| HLA-DRA | major histocompatibility complex, class II, DR alpha | 0.030 | ||
| CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | 0.029 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.029 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.029 | ||
| EPOR | erythropoietin receptor | 0.029 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.028 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.028 | ||
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.027 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.027 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.027 | ||
| ANXA2 | annexin A2 | 0.027 | Human | |
| ARRDC3 | arrestin domain containing 3 | 0.027 | ||
| BID | BH3 interacting domain death agonist | 0.026 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.025 | ||
| S100A11 | S100 calcium binding protein A11 | 0.024 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.023 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.023 | ||
| VIM | vimentin | 0.023 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.023 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.022 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.022 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.022 | Rat | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.022 | Rat | |
| TGFB3 | transforming growth factor, beta 3 | 0.021 | ||
| IRS1 | insulin receptor substrate 1 | 0.021 | ||
| HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.020 | ||
| HLA-DMB | major histocompatibility complex, class II, DM beta | 0.020 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.020 | ||
| ANXA5 | annexin A5 | 0.020 | Human | |
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.020 | ||
| HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.020 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.019 | ||
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.019 | ||
| NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.019 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.018 | ||
| S100A4 | S100 calcium binding protein A4 | 0.018 | ||
| LAT | linker for activation of T cells | 0.017 | ||
| IER2 | immediate early response 2 | 0.017 | ||
| FAM107A | family with sequence similarity 107, member A | 0.017 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.017 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.017 | ||
| BAD | BCL2-associated agonist of cell death | 0.016 | ||
| LY96 | lymphocyte antigen 96 | 0.016 | ||
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.016 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.016 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.016 | ||
| RUNX1 | runt-related transcription factor 1 | 0.016 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.016 | ||
| HAX1 | HCLS1 associated protein X-1 | 0.015 | ||
| MYLK2 | myosin light chain kinase 2 | 0.015 | ||
| EGR1 | early growth response 1 | 0.015 | ||
| AHR | aryl hydrocarbon receptor | 0.015 | Rat | |
| CCL4 | chemokine (C-C motif) ligand 4 | 0.015 | ||
| MAD2L2 | MAD2 mitotic arrest deficient-like 2 (yeast) | 0.015 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.015 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.015 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.014 | ||
| HLA-DRB5 | major histocompatibility complex, class II, DR beta 5 | 0.014 | ||
| S100A2 | S100 calcium binding protein A2 | 0.014 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.014 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.014 | ||
| DUSP6 | dual specificity phosphatase 6 | 0.013 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.013 | ||
| TP53 | tumor protein p53 | 0.013 | ||
| CSF3 | colony stimulating factor 3 (granulocyte) | 0.013 | ||
| AGXT2 | alanine--glyoxylate aminotransferase 2 | 0.013 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.013 | ||
| PRDX1 | peroxiredoxin 1 | 0.013 | ||
| SKIL | SKI-like oncogene | 0.013 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.013 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.013 | ||
| INO80B | INO80 complex subunit B | 0.012 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.012 | ||
| CTTN | cortactin | 0.012 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.012 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.012 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.012 | Rat | |
| PGK1 | phosphoglycerate kinase 1 | 0.012 | ||
| CCND1 | cyclin D1 | 0.012 | Rat | |
| SIRT2 | sirtuin 2 | 0.012 | ||
| EID1 | EP300 interacting inhibitor of differentiation 1 | 0.012 | ||
| UBE2L6 | ubiquitin-conjugating enzyme E2L 6 | 0.012 | Human | |
| DARC | Duffy blood group, chemokine receptor | 0.011 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.011 | Rat | |
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.011 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
| IL6R | interleukin 6 receptor | 0.011 | Rat | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.011 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.011 | Rat | |
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.011 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.011 | ||
| HLA-DPB1 | major histocompatibility complex, class II, DP beta 1 | 0.011 | ||
| RNR2 | l-rRNA | 0.010 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.010 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.010 | ||
| JUND | jun D proto-oncogene | 0.010 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.010 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.010 |